ASN Kidney Week Returns to Philadelphia to Highlight Latest Innovations, Issues in Renal Care
October 30th 2023The American Society of Nephrology (ASN) Kidney Week 2023 will take place in Philadelphia, Pennsylvania, from November 2-5, as experts from across the globe gather to discuss the latest innovations in renal care and current issues facing the field.
Read More
STELLAR, SOTERIA Data Provide Insight Into Effects of Sotatercept in Pulmonary Arterial Hypertension
October 28th 2023At ERS International Congress 2023, new data related to use of sotatercept offered providers additional insight into the effects of the agent in people with pulmonary arterial hypertension (PAH).
Read More
Ixazomib Shows Efficacy, Tolerability in Real-World R/R Multiple Myeloma Treatment
October 28th 2023A study of patients with relapsed or refractory (R/R) multiple myeloma who received ixazomib-based therapy in real-world settings found the treatment effective and tolerable in clinical practice.
Read More
ANNEXA-I: Andexanet Alfa Shows Efficacy, Safety for Factor Xa Reversal in Acute ICH
October 27th 2023The phase 4 ANNEXA-I trial was stopped early after showing superior hemostatic efficacy and the capability to limit potentially life-threatening intracerebral hemorrhage (ICH) compared with usual care in patients taking oral factor Xa (FXa) inhibitors.
Read More
Dr Melissa Levine on Implementing Value-Based Care in the Primary Care Setting
October 26th 2023Melissa Levine, MD, a family medicine specialist at Arizona Community Physicians and medical director for the Abacus Health accountable care organization (ACO), discussed strategies for succeeding in an ACO and how primary care can complement oncology care for patients with cancer.
Read More
Exon-Skipping Therapy for DMD Linked to High Care Costs, Health Care Resource Utilization
October 25th 2023This comprehensive comparative analysis examined the economic and health care resource utilization implications of initiating glucocorticoid and exon-skipping therapy for Duchenne muscular dystrophy (DMD).
Read More
GALACTIC Trial Reveals Less Successful RAAS Inhibitor Uptitration in Women Than Men
October 24th 2023Uptitration of renin-angiotensin-aldosterone system (RAAS) inhibitors was less successful in women than men with acute heart failure (AHF), especially in those with HF with reduced ejection fraction.
Read More
Amivantamab Plus Lazertinib Improved PFS for EGFR-Mutated Advanced NSCLC
October 23rd 2023MARIPOSA demonstrated the combination reduced risk of progression or death by 30% compared with osimertinib. MARIPOSA-2 found amivantamab plus chemotherapy and amivantamab plus chemotherapy and lazertinib also improved progression-free survival (PFS) over chemotherapy after progression on osimertinib.
Read More
Dr Lalan Wilfong: Patients Deserve the Full Benefit of Everything We Can Provide
October 23rd 2023At the 2023 COA Payer Exchange Summit being held October 23-24 in Reston, Virginia, Lalan Wilfong, MD, US Oncology Network, emphasizes the importance of oncology care equity, ensuring continuity of care, and enhancing care coordination.
Watch
Zanubrutinib Associated With Better OS in Second vs Later Lines of R/R MCL Therapy
October 23rd 2023A pooled analysis with nearly 3 years of follow-up showed better outcomes when zanubrutinib was given in the second line vs later lines of therapy in patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL).
Read More
FDA Allows At-Home Dosing of Intranasal Foralumab for Multiple Sclerosis
October 23rd 2023The FDA’s decision to allow at-home dosing of intransal foralumab for patients with multiple sclerosis is likely to improve patient compliance to treatment and health outcomes, according to a recent release statement.
Read More
Darker Skin Means Different Presentations of Skin Diseases, Explains Dr James Song
October 23rd 2023Recognizing that skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa present differently in skin of color can prevent delays in diagnosis and treatment, explained James Song, MD, director of clinical research and associate chief medical officer at Frontier Dermatology.
Read More